Carboplatin NDC 69339-365

Product information

Brand name (proprietary)

Carboplatin

Generic name (nonproprietary)

carboplatin

Active ingredients

Carboplatin — 150 mg/15mL

Dosage form

Injection, Solution

Route

Intravenous

Labeler

Natco Pharma USA LLC

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 077861

Marketing start

Jul 2, 2026

Listing expires

Dec 31, 2027

Other FDA classes

Platinum-containing Compounds (EXT)

Identifiers

Product ID 69339-365_4c89cedc-e48b-445c-ad05-54dbe60e4fb0SPL ID 4c89cedc-e48b-445c-ad05-54dbe60e4fb0SPL set ID 4c89cedc-e48b-445c-ad05-54dbe60e4fb0RxCUI 597195UNII BG3F62OND5UPC 0369339364055, 0369339367605, 0369339365151, 0369339366455

Pharmacologic class

Platinum-based Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N469339036515 followed by a unit qualifier and the quantity Copy

Package 69339-0365-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 077861

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.